Correlation Between Cue Biopharma and Abcam PLC
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Abcam PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Abcam PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Abcam PLC, you can compare the effects of market volatilities on Cue Biopharma and Abcam PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Abcam PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Abcam PLC.
Diversification Opportunities for Cue Biopharma and Abcam PLC
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cue and Abcam is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Abcam PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcam PLC and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Abcam PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcam PLC has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Abcam PLC go up and down completely randomly.
Pair Corralation between Cue Biopharma and Abcam PLC
If you would invest (100.00) in Abcam PLC on December 11, 2024 and sell it today you would earn a total of 100.00 from holding Abcam PLC or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Cue Biopharma vs. Abcam PLC
Performance |
| Timeline |
| Cue Biopharma |
| Abcam PLC |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Cue Biopharma and Abcam PLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Abcam PLC
The main advantage of trading using opposite Cue Biopharma and Abcam PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Abcam PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcam PLC will offset losses from the drop in Abcam PLC's long position.| Cue Biopharma vs. Coya Therapeutics, Common | ||
| Cue Biopharma vs. Lantern Pharma | ||
| Cue Biopharma vs. Fennec Pharmaceuticals | ||
| Cue Biopharma vs. Anixa Biosciences |
| Abcam PLC vs. Anebulo Pharmaceuticals | ||
| Abcam PLC vs. Adagene | ||
| Abcam PLC vs. Acrivon Therapeutics, Common | ||
| Abcam PLC vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |